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Summary. In the present work we analyze the
cerebellum of chronic parkinsonian monkeys in order to
clarify whether chronic mesencephalic depletion is
associated with long term activation of the cerebellar
neurons in chronic Parkinsonism. In our study, we
observed a persistent activation of Purkinje cells in the
cerebellum of chronic parkinsonian macaques,
characterized by the expression of c-Fos, which
correlated with dopaminergic degeneration. These
results are compatible with the results observed in fMRI
in Parkinson’s disease patients, and may contribute to
the understanding of additional alterations in the brain
circuitry in Parkinsonism.
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Introduction
Previous reports have shown increased activity of
the cerebellum measured by fMRI in patients with
Parkinson’s disease (PD) (Rascol et al., 1997; Cerasa et
al., 2006; Yu et al., 2007), and various studies performed
in experimental models of PD have shown particular
cerebellar alterations, which suggests that cerebellum
activity may be related with dopaminergic neuronal loss
and be implicated in parkinsonian symptoms. Previous
studies in an MPTP-induced model in mice show
neuronal degeneration in the cerebellum (Takada et al.,
1993), characterized by the loss of Nissl-stained Purkinje
cells and aggravated by the number of repeated MPTP
injections. Other studies performed in monkeys have
also reported the loss of calcium-binding positive (CB-
D28k+) Purkinje cells shortly after the MPTP insult
(Vignola et al., 1994).
Previous studies analyzing the cerebellar alterations
of parkinsonian monkeys and mice have also reported an
increase in c-Fos expressing cells in the cerebellum of
MPTP-treated animals but only showing acute effects of
the systemic intoxication (Chen et al., 2001; Necchi et
al., 2004). In fact, in both reports this increase in c-Fos
was connected to apoptotic events occurring in the
cerebellum shortly after the neurotoxin insult. However,
it is necessary to ascertain whether this effect persists in
a chronic model of Parkinsonism and whether it is
correlated with dopaminergic neuronal loss. As previous
findings in this matter have been based on acute models
of Parkinsonism (Chen et al., 2001; Necchi et al., 2004),
in the present work we have analyzed the brains of
parkinsonian monkeys two years after the neurotoxin
insult in order to elucidate whether the activation of
Purkinje cells in the cerebellum may persist long-term,
since it is known that chronic nigrostriatal denervation
results in a decrease in the metabolic activity of thalamic
neurons in the territories innervated by the cerebellum
(Rolland et al., 2007). In this study, we quantified the
number of Nissl stained Purkinje cells and the number of
Calbindin D28k+ Purkinje cells in the cerebellum using
stereological methods. In addition, since it is not clear
whether the loss of dopaminergic neurons correlates with
alterations in the cerebellum, we performed a detailed
analysis of the number of cerebellar Purkinje cells and
their activity, as measured by c-Fos expression, and
compared the findings with different levels of
dopaminergic degeneration.
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Material and methods
Stereological analysis
For the present study we used brain tissue from
chronic parkinsonian macaques (Macaca fascicularis)
which were studied previously in our Primate Unit
(Barcia et al., 2004). All studies were carried out in
accordance with the Helsinki Declaration, the
International Primatological Society Guidelines and the
Guide for the Care and Use of Laboratory Animals
(National Research Council, NIH Guide revised 1996),
and with the norms of the state members of the European
Union (2003/65/CE), the Guidelines of the European
Convention for the protection of Vertebrate Animals
used for Experimental and other scientific purposes of
the Council of Europe of 2006, and the European
Communities Council Directive 2010/63/ECC. All
efforts were made to minimize animal suffering and to
reduce the number of animals used and to utilize
alternatives to in vivo techniques. Six adult macaques (5
males and 1 female) were treated every other week
during three months with low intravenous doses of
MPTP (0.3 mg/kg) according to previous protocols
(Herrero et al., 1993; Barcia et al., 2003). Each animal
received a different number of doses according to the
level of Parkinsonism and their susceptibility to MPTP
(Fig. 1A). None of them received L-DOPA or
dopaminergic agonists. Motor symptoms were assessed
using a previously described rating scale (Herrero et al.,
1993). The motor score of the animals used for this
study ranged from 0 to 10 and their postmortem analysis
revealed different degrees of dopaminergic depletion
according to their motor score. The sacrifice, perfusion
and fixation of the animals were performed as previously
described (Barcia et al., 2011). Two years after the last
MPTP dose animals were anaesthetized with an
overdose with pentobarbital (100 mg/Kg) and
transcardially perfused-fixed with 2-5 L of saline
solution. Immediately afterwards, the animals were
perfused with 4% paraformaldehyde to fix the tissue.
Brains were removed and sectioned by microtome
(Microm® HM400) into 40 µm thick sections. For the
present experiment, we classified the animals according
to the dopaminergic (DA) depletion of the SNpc:
animals with preserved (PR) SNpc, those with moderate
depletion (MD) (less than 50%) of DA neurons of the
SNpc, and animals with severe depletion (SD) (more
than 50%) of nigral DA neurons (Fig. 1A,B).
The fixed cerebellum was sectioned into sagittal
serial sections while the SNpc was sectioned into
coronal sections. Series of sections regularly spaced at
intervals of 1,440 µm were stained with thionin.
Adjacent sections were immunostained to visualize
Calbinding D28k (CB D28k) (mouse monoclonal
antibody 1:500; Chemicon, Temecula, CA, USA) in
order to quantify the Purkinje cells in the MPTP-
intoxicated monkeys, c-Fos (rabbit polyclonal antibody
1:500; Santa Cruz, CA, USA) to analyze the neuronal
activation in the Purkinje cells of parkinsonian monkeys,
and tyrosine hydroxylase (TH) (sheep polyclonal
antibody 1:1000; Chemicon, Temecula, CA, USA) in
order to quantify the neuronal loss in the SNpc of
MPTP-intoxicated monkeys. Sections from all the
animals were stained simultaneously and under the same
experimental conditions as previously described (Barcia
et al., 2004). Sections of the cerebellum and the SNpc
(40 µm) were used for immunohistochemistry to detect
specific cells. Cerebellum and SNpc were defined
according to the Monkey Brain Atlas (Paxinos et al.,
2000). Nissl stained or DAB labeled cells were
quantified in serial sagittal sections from each animal.
The number of cells was estimated with an optical
fractionator probe using a computer assisted image
analysis system (Image J, © 2009 Burger and Burge;
ScionImage, Frederick, Maryland, USA) with a Zeiss
Axioplan 2 microscope connected to a digital camera.
The area of interest was traced using a 1.25x objective.
The number of cells was measured in 200x200 µm
dissectors covering the surface of the analyzed area.
Labeled cells were counted using the 40x objective and
counting frames throughout the delineated area of the
SNpc in the right and left hemisphere and in the
cerebellar gyrus in each section via the optical
fractionator. Serial sections of the monkey cerebellum
were used for quantification of the number of Purkinje
cells in the Purkinje layer of the cerebellar cortex. Data
were expressed as an absolute number of positive cells
in each anatomical area analyzed considering both
hemispheres. The results are expressed as the mean ±
SEM. The volume of the cerebellum was measured
using scanned images of the Nissl stained series of
sections following Cavalieri’s method (Gundersen,
1986) (Fig. 1C). All the quantifications were done
blindly by a researcher (P.H.) who did not know the
degree of Parkinsonism of the animals.
Statistical analysis
Data are expressed as mean ± SEM. Since groups of
2 animals would be insufficient to assess statistically
significant data, statistical analysis was performed using
a Pearson correlation. The null hypothesis was rejected
for an α risk equal to 5%.
Results
Cerebellar volume does not change with Parkinsonism in
MPTP-treated monkeys
We analyzed animals with different degrees of
dopaminergic neuronal loss: PR, MD and SD monkeys
(Fig. 1A,B). In order to analyze changes in the
cerebellum according to the dopaminergic cell loss, we
first analyzed the volume of the cerebellum. Since the
density of neurons could vary with changes of the total
volume of the nucleus, the total volume of each
cerebellum was measured and no apparent differences
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quantified in the cerebellum with an optical dissector
(optical fractionator) and compared with the degree of
Parkinsonism (Fig. 2A top chart). Although a trend of
correlation was seen, no significant differences were
found between the loss of the number of thionin+
Purkinje cells and the degree of dopaminergic neuronal
loss in the SNpc (Fig. 2B top chart).
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Fig. 1. Study of the levels of
dopaminergic neuronal loss in
the SNpc of MPTP-treated
macaques with different
degrees of Parkinsonism. A.
Pictures of TH immunostaining
of the SNpc of an intact
monkey (CTR), a PR monkey
(M2), an MD monkey (M4) and
an SD monkey (M6). The top
row of pictures were taken at
low magnification (1-4) and the
bottom row of pictures were
taken at higher magnification.
Scale bar in 4: 1 mm; scale
bar in 4’: 100 µm. B. Graph
shows the different degree of
dopaminergic cell loss in the
SNpc of monkeys treated with
MPTP. The histogram shows
the average of the number of
TH+ neurons of the SNpc of 4
intact monkeys in the same
conditions (n=4). C. Volume of
Monkey Cerebellum does not
change with the different levels
of DA depletion. Series of
sections of the cerebellum
were stained with thionin and
the total volume was
measured by Cavalieri ’s
stereological method and
compared between the
animals. No major differences
were observed between the
groups. Cerebellar serial
sections of two representative
animals are shown. D.
Inserted table shows the
volumes of the cerebellum
calculated by Cavalieri 's
method in all the studied
monkeys. No volume
differences were observed
between the animals
according to the DA depletion.
PR, Preserved SNpc; MD,
Moderately depleted SNpc;
SD, Severely depleted SNpc.
were detected according to the level of DA depletion
(Pearson coefficient R2= -0.3) (Fig. 1D).
MPTP –treated monkeys show no clear correlation
between the loss of Purkinje cells and DA depletion
The number of thionin+ Purkinje cells was
differences were noted with respect to the severity of
Parkinsonism.
Persistent c-Fos expression in the Purkinje cells in
parkinsonian animals
Since Purkinje cells are the putative cell type to be
overactivated in Parkinsonism, and their activation may
persist after mesencephalic dopaminergic degeneration,
serial sections of the cerebellum were stained with an
antibody against c-Fos, a well-known protein expressed
when neurons fire action potentials, and commonly used
as an indirect marker of neuronal activity (Luckman et
al., 1994; Fields et al., 1997). Immunostaining of c-Fos
in serial sections of cerebellum revealed some well-
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Fig. 2. The degree of persistent expression of c-Fos+ in Purkinje cells correlates with the degree of mesencephalic dopaminergic degeneration in
parkinsonian monkeys. A, top row: Parkinsonian monkeys do not show clear correlation between thionin+ Purkinje cell degeneration in cerebellum and
mesencephalic DA depletion. A. Sections of the cerebellum were stained with thionin in PR, MD and SD monkeys. Inserts show pictures of higher
magnification of thionin+ Purkinje cells. Arrows indicate typical Purkinje cells magnified in the insert. The Purkinje cells were clearly observed between
the granular and molecular layers in the cerebellar cortex (arrows) and quantified by stereological methods. B, top chart: There was no significant
correlation between the number of Purkinje cells and the loss of dopaminergic neurons of the SNpc. A, middle row: The loss of Calbindin D28k
expressing Purkinje cells does not correlate with the level of Parkinsonism. Sections of the cerebellum were immuno-stained for CB-D28k in monkeys
PR, MD and SD. The Purkinje cells were clearly stained and quantified with stereological methods. B, middle chart: There was no significant correlation
between the number of CB-D28k+ Purkinje cells and the loss of dopaminergic neurons of the SNpc. A, bottom row: The number of c-Fos expressing
Purkinje cells strongly correlates with the degree of Parkinsonism. A. Sections of the cerebellar cortex were immunostained for c-Fos in monkeys with
PR, MD and SD. The Purkinje cells were clearly stained and quantified with stereological methods. B, bottom chart: The correlation between the
number of c-Fos+ Purkinje cells and the loss of dopaminergic neurons of the SNpc revealed an increase of c-Fos in the animals with higher neuronal
dopaminergic loss. The analysis revealed a very strong and statistically significant correlation between c-Fos expression in cerebellar cortex and the
density of dopaminergic neurons in the SNpc.
Since previous reports mentioned a decrease in CB-
D28k+ Purkinje cells in MPTP-treated monkeys shortly
after the neurotoxin insult (Vignola et al., 1994), we also
analyzed these neurons in order to see whether this
change was correlated with the degree of parkinsonism.
For this, serial sections of the cerebellum were immuno-
stained with an antibody against CB-D28k, and CB-
D28k+ Purkinje cells were quantified with the same
stereological method used for Nissl-stained (thionin+)
Purkinje cells (Fig. 2A, middle row). We also analyzed
the percentage of the total number of Purkinje cells,
revealed by Nissl staining, which express CB D28k. In
all the groups of animals only 40% of the total number
of Purkinje cells was able to express CB D28k. Purkinje
cells were clearly present in the cerebellar cortex but no
or with dopaminergic agonists. Purkinje cells presented a
hyper-activation which correlated with the level of
dopaminergic neuronal loss in the SNpc (Fig. 2), which
may be crucial for the understanding of cerebellar
alterations observed in Parkinsonism.
Although not significant, we observed a certain
correlation between the loss of the number of Nissl+
Purkinje cells and the loss of dopaminergic neurons (Fig.
2). Probably a higher number of animals would be
needed to reach statistical significance. Previous studies
performed in MPTP-treated mice reported a loss of
cerebellar Nissl-stained Purkinje cells that worsens with
increasing doses of MPTP in mice (Takada et al., 1993;
Vignola et al., 1994). Our data indicate that MPTP may
have some effect on the cerebellum of animals with high
degree of Parkinsonism but probably higher doses of
MPTP may be needed to exert a massive Purkinje cell
toxicity as occurs in mice.
A previous study performed in monkeys acutely
treated with MPTP described degeneration of Purkinje
cells, however they stained with calcium binding
proteins (Vignola et al., 1994). Even known that calcium
binding protein has been used as a classical marker for
Purkinje cells in primates (Fortin et al., 1998), not all
Purkinje cells are positive for calcium-binding protein.
In our study only 40% of the Nissl-stained Purkinje cells
were positive for CB-D28k. In fact, we do observed no
evident correlation between CB-D28k+ Purkinje cells
and mesencephalic dopaminergic depletion. The results
observed in Vignola’s work may be due to the direct
toxicity of the MPTP exerted over CB-D28k+ Purkinje
cells, although according to our results this phenomenon
seems to be independent of mesencephalic dopaminergic
degeneration.
We demonstrated that the cortex of the cerebellum
presents hyper-activation of Purkinje cells, characterized
by the persistent expression of c-Fos years after MPTP
insult (Fig. 2A, bottom row). This activation of Purkinje
cells in chronic parkinsonian monkeys certainly
correlates with the level of neuronal degeneration of the
SNpc (Fig. 2B, bottom chart), which may be due to a
compensatory mechanism derived from the defective
basal ganglia circuitry, as occurs in patients with PD
(Rascol et al., 1997; Cerasa et al., 2006; Yu et al., 2007).
Previous reports have shown an increase of c-Fos in
the cerebellum of mice and monkeys shortly after the
MPTP insult (Chen et al., 2001; Necchi et al., 2004).
The authors of both reports linked the increase in c-Fos
with the induction of neuronal loss in the cerebellum.
The work of Necchi and coworkers (2004) points to an
increase in c-Fos in some Purkinje cells of the cerebellar
cortex but also in astrocytes located in the white matter,
which may be related with the immediate and general
effect of the toxin. In contrast, in our study, Purkinje
cells remained over-activated over a period of two years,
probably caused by persistent dopaminergic
mesencephalic loss. These results are compatible with
previous results which show the hypoactivity of the
cerebellar-thalamic pathways, which might therefore be
implicated in the development of parkinsonian
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Fig. 3. Diagram of the putative alteration of the cerebellar circuit in
Parkinsonism. In normal conditions Purkinje cells (PC) send inhibitory
signals to the neurons of the nucleus dentatus (DN). The DN sends
activation signals to the Thalamus (Th). As in Parkinsonism (MPTP
model in non-human primates), PC appear hyper-activated, then they
can highly inhibit the neurons of DN projecting to the Thalamus which
may apply to a reduced activation over thalamic neurons.
stained c-Fos+ Purkinje cells in the cerebellar cortex
(Fig. 2A, bottom row). Using stereological methods we
observed an increase in the number of c-Fos+ Purkinje
cells in the cerebellar cortex and the extent of the
increase depended on the degree of mesencephalic
dopaminergic depletion (Pearson coefficient R2= -0.9,
p<0.05) (Fig. 2B, bottom chart).
Discussion
In the present study, we performed a detailed
histological analysis in brain slices of the cerebellum of
chronic parkinsonian monkeys not treated with L-DOPA
symptoms (Rolland et al., 2007) (Fig. 3), as well as with
observations made with fMRI in patients with
Parkinson’s disease (PD) (Yu et al., 2007). So, we
suggest that the loss of dopaminergic neurons may have
an effect on the activity of cerebellar neurons and have
implications in the clinical syndrome and in the
physiopathology of PD.
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